Illness	Number of cases
Malignant neoplasm of pancreas - Malignant neoplasm of head of pancreas (C25.0)	382
Malignant neoplasm of rectum (C20)	343
Malignant neoplasm of colon - Malignant neoplasm of sigmoid colon (C18.7)	199
Malignant neoplasm of stomach - Malignant neoplasm of cardia (C16.0)	161
Malignant neoplasm of ovary (C56)	141
Malignant neoplasm of colon - Malignant neoplasm of ascending colon (C18.2)	140
Malignant neoplasm of pancreas - Malignant neoplasm of body of pancreas (C25.1)	123
Non-follicular lymphoma (C83.3)	114
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	103
Malignant neoplasm of breast (C50.9)	88

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	2.257
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22)	1.566
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	1.352
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	690
(9-984.7)	356
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.21)	324
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	230
(9-984.b)	220
Treatment procedure to maintain and encourage practical everyday and social skills - psychosocial intervention (9-401.30)	212
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.13)	196

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500 , 0592

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
166	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
129	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
129	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies
Project-related cooperation with colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Student training (clinical traineeship / internship year)
Lectureships / teaching posts at colleges and universities
Doctoral supervision
Editors of scientific journals/textbooks

Training

No.	Training in other healing professions	Comment
HB20	Nursing professional B. Sc.	In Kooperationen mit Münchener Hochschulen
HB19	Nursing professionals
HB15	Anaesthesia technical assistant (m/f)
HB07	Surgical technical assistant (m/f)
HB17	Auxiliary nurse (m/f)